
PepsiCo CEO Ramon Laguarta today (10 October) dismissed rising concerns around GLP-1 drugs and their potential impact on drinks businesses.
Continued price increases drove positive results as the company’s organic volume fell 2.5% for the latest quarter.
PepsiCo CEO Ramon Laguarta today (10 October) dismissed rising concerns around GLP-1 drugs and their potential impact on drinks businesses.